REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 82 filers reported holding REVANCE THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $28,939,000 | +35.5% | 1,398,009 | +6.1% | 0.01% | +25.0% |
| Q3 2016 | $21,360,000 | +31.5% | 1,317,731 | +10.3% | 0.00% | 0.0% |
| Q2 2016 | $16,243,000 | -19.1% | 1,194,355 | +3.8% | 0.00% | -20.0% |
| Q1 2016 | $20,088,000 | -44.0% | 1,150,499 | +9.6% | 0.01% | -37.5% |
| Q4 2015 | $35,859,000 | +60.0% | 1,049,725 | +39.4% | 0.01% | +33.3% |
| Q3 2015 | $22,408,000 | -2.8% | 752,964 | +4.4% | 0.01% | 0.0% |
| Q2 2015 | $23,058,000 | +105.3% | 720,999 | +33.1% | 0.01% | +100.0% |
| Q1 2015 | $11,230,000 | +28.6% | 541,727 | +5.1% | 0.00% | +50.0% |
| Q4 2014 | $8,734,000 | +124.1% | 515,592 | +155.7% | 0.00% | +100.0% |
| Q3 2014 | $3,898,000 | -35.0% | 201,636 | +14.4% | 0.00% | -50.0% |
| Q2 2014 | $5,995,000 | +0.3% | 176,314 | -7.1% | 0.00% | 0.0% |
| Q1 2014 | $5,977,000 | – | 189,747 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $94,714,000 | 24.58% |
| Palo Alto Investors LP | 2,673,313 | $75,762,000 | 3.97% |
| Evolutionary Tree Capital Management, LLC | 89,348 | $2,532,000 | 1.93% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,121,152 | $31,773,000 | 1.12% |
| ArrowMark Colorado Holdings LLC | 2,964,135 | $84,004,000 | 0.65% |
| Rhenman & Partners Asset Management AB | 220,000 | $6,235,000 | 0.51% |
| Fosun International Ltd | 233,841 | $6,627,000 | 0.43% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 174,970 | $4,959,000 | 0.30% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 76,671 | $2,173,000 | 0.27% |
| Tekla Capital Management LLC | 213,808 | $6,059,000 | 0.21% |